{"id":1194738,"date":"2023-08-29T22:48:54","date_gmt":"2023-08-29T22:48:54","guid":{"rendered":"https:\/\/theintercept.com\/?p=443161"},"modified":"2023-08-29T22:48:54","modified_gmt":"2023-08-29T22:48:54","slug":"biden-administration-adds-insulin-to-drug-price-negotiation-list-in-major-blow-to-big-pharma","status":"publish","type":"post","link":"https:\/\/radiofree.asia\/2023\/08\/29\/biden-administration-adds-insulin-to-drug-price-negotiation-list-in-major-blow-to-big-pharma\/","title":{"rendered":"Biden Administration Adds Insulin to Drug Price Negotiation List in Major Blow to Big Pharma"},"content":{"rendered":"
The Biden administration<\/u> pleasantly stunned health care reform advocates Tuesday by including short-acting insulin in its list<\/a> of 10 drugs for which Medicare will negotiate lower prices, power vested in the White House by the Inflation Reduction Act. <\/p>\n The IRA was passed in the face of one of the heftiest barrages of lobbying in congressional history, with the pharmaceutical industry spending more than $700 million over 2021 and 2022<\/a> \u2014 several times more than the second- and third-ranking industries \u2014 much of it aimed at stopping the legislation, watering it down, or undermining its implementation. <\/p>\n <\/p>\n\n Most Read <\/h2>\n